@sigh_d There is no cure for MS, so I will likely be on some form or other of treatment for the rest of my life. If this one keeps me from relapsing then maybe this one. Since #rituximab is killing off part of my immune system, if it works I’ll probably be able to drop it to once a year or so, though.

Infusion for #MultipleSclerosis is officially done! And this time I got smart and took a couple days off so I don’t wind up in urgent care again. Woohoo!!! No more treatments for six months. Just an MRI and neuro appointment between treatments. #rituximab #FuckMS #rituxan

I have my twice yearly #rituximab infusion for MS tomorrow. I’ve loaded up on snacks and I’m gonna charge my Switch, grab a book and download some tv. I’m lowkey stressed about it. Writing codes at the Co-Op backwards and shit.
Last 2x I ended up in urgent care because the directions about getting checked out for issues after infusion are pretty scary. Here’s to me knowing what to expect and not having issues this time! #rituxan #pwms #fuckMS

💊💉 #rituximab SmPC for Ruxience 500 mg concentrate for solution for infusion has been updated with changes to sections 4.4 Special warnings; 4.8 Undesirable effects; 5.1 Pharmacodynamic; 5.2 Pharmacokinetic; 6.3 Shelf life; 6.4 Special precautions for storage; Revised: 12/2024 Ref: bRI 12_0. 🌐 https://www.medicines.org.uk/emc/product/11793/smpc Change log: https://www.medicines.org.uk/emc/product/11793/smpc/history

💊💉 #rituximab SmPC for Ruxience 100 mg concentrate for solution for infusion has been updated with changes to sections 4.4 Special warnings; 4.8 Undesirable effects; 5.1 Pharmacodynamic; 5.2 Pharmacokinetic; 6.3 Shelf life; 6.4 Special precautions for storage; 6.6 Special precautions for disposal; Revised: 12/2024 Ref: bRI 12_0. 🌐 https://www.medicines.org.uk/emc/product/11792/smpc Change log: https://www.medicines.org.uk/emc/product/11792/smpc/history

💊💉 #rituximab SmPC for Truxima 500 mg concentrate for solution for infusion has been updated with changes to sections 4.1 Therapeutic indications; 4.2 Posology; 4.3 Contraindications; 4.4 Special warnings; 4.6 Fertility, pregnancy; 4.8 Undesirable effects; 5.1 Pharmacodynamic; 5.2 Pharmacokinetic; 5.3 Preclinical safety data; 6.3 Shelf life; 6.4 Special precautions for storage; 6.6 Special precautions for disposal; Revised: 30/09/2024. 🌐 https://www.medicines.org.uk/emc/produ ...

💊💉 #rituximab SmPC for Truxima 100 mg concentrate for solution for infusion has been updated with changes to sections 4.1 Therapeutic indications; 4.2 Posology; 4.3 Contraindications; 4.4 Special warnings; 4.6 Fertility, pregnancy; 4.8 Undesirable effects; 5.1 Pharmacodynamic; 5.2 Pharmacokinetic; 5.3 Preclinical safety data; 6.3 Shelf life; 6.4 Special precautions for storage; 6.6 Special precautions for disposal; Revised: 30/09/2024. 🌐 https://www.medicines.org.uk/emc/produ ...

💊💉 #rituximab
SmPC for MabThera 1400 mg solution for subcutaneous injection has been updated with changes to sections 4.8 Undesirable effects; 10. Date of revision of the text on 15 August 2024.
🌐 https://www.medicines.org.uk/emc/product/5333/smpc
Change log: https://www.medicines.org.uk/emc/product/5333/smpc/history

💊💉 #rituximab SmPC for MabThera 100 mg concentrate for solution for infusion MabThera 500 mg concentrate for solution for infusion has been updated with changes to sections 2. Qualitative; 4.1 Therapeutic indications; 4.2 Posology; 4.3 Contraindications; 4.4 Special warnings; 4.6 Fertility, pregnancy; 4.8 Undesirable effects; 4.9 Overdose; 5.1 Pharmacodynamic; 5.2 Pharmacokinetic; 5.3 Preclinical safety data; 6.2 Incompatibilities; 6.3 Shelf life; 6.4 Special precautions for ...

💊💉 #rituximab SmPC for MabThera 100 mg concentrate for solution for infusion MabThera 500 mg concentrate for solution for infusion has been updated with changes to sections 2. Qualitative; 4.1 Therapeutic indications; 4.2 Posology; 4.3 Contraindications; 4.4 Special warnings; 4.6 Fertility, pregnancy; 4.8 Undesirable effects; 4.9 Overdose; 5.1 Pharmacodynamic; 5.2 Pharmacokinetic; 5.3 Preclinical safety data; 6.2 Incompatibilities; 6.3 Shelf life; 6.4 Special precautions for ...